Blood Irradiation Market Forecast 2021-2027 | Size, Share, Growth, Trends, Segmentation, Analysis and In-Depth Research Report 2021

SEATTLE, April 08, 2021, (PHARMIWEB) — Global Blood Irradiation Market

Blood irradiation is a therapy in which blood components are irradiated prior to transfusion, to prevent proliferation of certain types of T lymphocytes. The T lymphocytes inhibit the immune responses and lead to a rare graft-versus-host disease (GVHD), with serious complications due to blood transfusion caused by white blood cells (WBCs). A small number of white blood cells can recognize the different blood in the body which may cause a serious illness, or even death.

Irradiated blood is treated with UV, X-rays or other forms of radioactive methods. Blood irradiation treated with UV rays is beneficial to cancer patients as it strengthens the immune system and improves overall health. Ultraviolet rays restrain viral, bacterial, and fungal growth and improves the body’s ability to detoxify and inactive toxins, which can further assist in the other cancer treatments. Based on this technique, three types of blood irradiation are available in the market i.e. intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1939

Global Blood Irradiation Market Insights

Growing global population that is highly vulnerable to various communicable and non-communicable diseases, such as cancer, chronic kidney disease, high blood pressure disease, stroke and cardiovascular diseases, which is expected to drive the global blood irradiation market growth. For instance, according to the World Bank’s 2016 report, the global population reached up to 7.44 billion.

According to a report by the World Health Organization (WHO) , in 2018, non-communicable diseases cause around 41 million deaths each year, which is equivalent to 71% of all deaths globally. Also, cardiovascular diseases account for 17.9 million deaths each year, followed by other respiratory diseases (3.9 million), diabetes (1.6 million), and cancer (9.0 million) respectively. Such increasing prevalence of non- communicable diseases boosts demand for quicker blood stream treatment, which in turn is expected to significantly propel growth of the global blood irradiation market.

Infections in the blood stream are diagnosed and irradiated by laser irradiation therapies. Increasing use of such therapies is driving manufacturers to develop innovative blood irradiation systems for improved health treatments, which is directly boosting the market growth. For instance, in 2017 thriveMD, a U.S.-based company, introduced ultraviolet blood irradiation (UVB) therapy, which is a photo-oxidation treatment that briefly exposes a sample of the blood to ultraviolet light.

However, regulatory policies regarding the medical systems and lack of skilled professionals in emerging economies are likely to hamper the market growth. For instance, The Center for Biologics Evaluation and Research (CBER) regulates the collection of blood and blood components used for transfusion, CBER develops and enforces quality standards, inspects blood establishments and monitors reports of errors, accidents and adverse clinical events.

Global Blood Irradiation Market – Regional Insights

North America accounted for the dominant position in the blood irradiation market, owing to growing awareness among the population regarding blood related diseases and launch of new innovative technology in the field of healthcare. For instance, in 2017, Typenex Medical launched Rad-Control, a new irradiation indicator tag technology for blood centers and blood banks in Canada and the U.S. This checks blood irradiation by visual verification, minimizes current documentation practices, and increases efficiency for healthcare staff.

Asia Pacific, followed by Europe, is expected to show tremendous growth in the global blood irradiation market. Rising population vulnerable to various chronic diseases and government involvement in maintaining safety standards for new product launches is expected to propel the blood irradiation market growth in the region. For instance, in 2015, UVLrx Therapeutics received CE Marking (European Conformity) for its intravenous UV light therapy device, that offers intravenous, concurrent delivery of ultraviolet-A (UVA), and multiple visible light wavelengths.

Global Blood Irradiation Market – Competitive Landscape

The major players operating in the global blood irradiation market include Typenex Medical, UVLrx Therapeutics, Best Theratronics, Hitachi Medical Systems, Actemium NDT-PES, Rad Source Technologies, and Gilardoni S.p.A.

These market contenders are actively engaged in the adoption of strategies, such as mergers, collaborations, new product launches, and partnerships, to retain their positions in the global market. For instance, in 2017 Typenex Medical exclusively partnered with a European manufacturer- On Point Indicators GmbH, to offer its product to customers.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1939

Global Blood Irradiation Market Taxonomy

On the basis of type:

• Intravenous Laser Blood Irradiation
• Transcutaneous Laser Blood Irradiation
• Extracorporeal Blood Irradiation

On the basis of end-use:

• Hospitals
• Blood Banks
• Diagnostic Clinics
• Research Institutes

By region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837